Esperion Virtual Research & Development Day to Highlight Pipeline Programs and Scientific Focus
09 nov. 2022 08h00 HE
|
Esperion Therapeutics, Inc.
– Event to Include Expert-Led Discussions on State of Cardiovascular Disease Treatments and Remaining Unmet Needs – – Esperion Leadership Will Provide Overview of its Investigational Pipeline,...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
08 nov. 2022 09h00 HE
|
InSilico Medicine
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
08 nov. 2022 09h00 HE
|
InSilico Medicine
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
DT Midstream Closes on Purchase of Additional Ownership in Millennium Pipeline
07 oct. 2022 16h15 HE
|
DT Midstream, Inc.
DETROIT, Oct. 07, 2022 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced that it has closed on the $552 million purchase of an additional 26.25% ownership interest in Millennium...
DT Midstream Increases Ownership in Millennium Pipeline
29 sept. 2022 07h30 HE
|
DT Midstream, Inc.
Premier, fully contracted pipeline with creditworthy customersImmediately accretive transactionConsistent with core investment thesis DETROIT, Sept. 29, 2022 (GLOBE NEWSWIRE) -- DT Midstream,...
SAB Biotherapeutics Advancing Pipeline and Expands into Treatment for C. Diff. as DoD Contract Winds Down
09 août 2022 16h30 HE
|
SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., Aug. 09, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces...
DT Midstream Reports Strong Second Quarter 2022 Results; Announces Next Phase Haynesville Expansion
03 août 2022 07h30 HE
|
DT Midstream, Inc.
Announces Phase 2 expansion of Haynesville systemReaffirms 2022 adjusted EBITDA guidance of $770 to $810 millionReaffirms 2023 adjusted EBITDA early outlook of $810 to $850 millionDeclares quarterly...
Compass Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
01 août 2022 08h00 HE
|
Compass Therapeutics
Phase 2/3 trial of CTX-009 (DLL4 X VEGF-A bispecific) and paclitaxel in biliary tract cancer (BTC) anticipated to begin in the United States in Q3 2022A Phase 2 trial of CTX-009 as a monotherapy in...
BLDUP Expands to Florida, Opening Third Regional Office
28 juil. 2022 11h00 HE
|
BLDUP, Inc.
BOCA RATON, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- BLDUP, a new, technology-driven CRE platform focused on the forward supply pipeline, is pleased to announce the launch of their latest market,...
Global Pipeline Construction Market Is Expected to Reach $73.1 Billion by 2031: Allied Market Research
23 juin 2022 08h10 HE
|
Allied Market Research
Portland, OR, June 23, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global pipeline construction market generated $45.7 billion in 2021, and is projected...